Effects of Simultaneous Knockdown of HER2 and PTK6 on Malignancy and Tumor Progression in Human Breast Cancer Cells
Natalie Ludyga(Helmholtz Zentrum München), Michaela Aubele(Helmholtz Zentrum München)
Cited by 23
Related Papers
MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion
|British Journal of Cancer|2013|58
The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancer
|Molecular Cancer|2013|53
Secreted uPAR isoform 2 (uPAR7b) is a novel direct target of miR-221
|Oncotarget|2015|15